跳至主要内容
临床试验/IRCT20180818040827N4
IRCT20180818040827N4已完成3 期

The effects of royal jelly supplementation on inflammatory status, oxidative stress, mental health, cognitive function, disease severity and quality of life in patients with ischemic stroke

Esfahan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 80 years(—)
性别
All

入选标准

  • Confirmed diagnosis of ischemic stroke by a neurologist
  • NIHSS score of 5-20
  • An absence of previous stroke or or MRS score of = 1 for those with previous stroke
  • Ischemic stroke of non-brain stem area
  • age of 45-80
  • Not following specific dietary regimen in previous 3 months
  • Not taking multivitamins and antioxidant supplements in the previous 3 months
  • Non pregnant and lactating women
  • No other diseases such as acute kidney, liver, heart, other neurological diseases, malignancies, no asthma, allergies and dermatitis
  • Not suffering from mental retardation (mental disabilities)
  • Not taking drugs that interfere with Royal Jelly supplementation (warfarin)
  • Lack of sensitivity and allergy to honey and its products

排除标准

  • Unwillingness to continue the study for any reason
  • Adherence of less than 80% to the intervention (taking less than 80% of Royal Jelly supplement that should be taken during the 12 weeks of the intervention will be considered low adherence)
  • Recurrence of stroke
  • Use of antioxidant and multivitamin supplements during the study
  • Prescription of warfarin during the study
  • Gastrointestinal side effects or allergies caused by taking Royal Jelly supplement
  • Diagnosis of other diseases such as kidney, autoimmune and malignancies during the study

研究者

相似试验

Effect of royal jelly in treatment of stroke | 临床试验